DoseMe Chief Scientific Officer, Dr Robert McLeay, will present at this years International Association of Therapeutic Drug Monitoring and Clinical Toxicology Congress (IATDMCT) from 16-17 September in Brisbane, Australia. Dr McLeay will present his work on "Barriers overcome: A case study of deploying model-informed precision dosing across five...
Read more
DoseMe today announced that DoseMeRx - the leading clinical decision support tool for precision dose calculations - has been selected for assessment by the University Hospitals of Leicester NHS Trust to optimize the dosing of vancomycin used in intensive care patients to treat MRSA blood stream infections. The project will evaluate...
Read more
DoseMeRx Leverages Pharmacometrics for Dose Optimization of Vancomycin DoseMeRx is unique precision dosing software that incorporates clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype (if applicable and available) to guide dose optimization.Designed exclusively to support physicians in making a rigorous, best-practice decision based on maximizing the use of...
Read more
Sugar Land, Texas – Healix, the nation’s leader in physician office based infusion services, announced a strategic relationship with DoseMe, a precision dosing decision support platform specifically for clinical practice. “We are really pleased to partner with DoseMe,” said Lucinda Van Anglen, B.S., PharmD, Senior Vice President of Pharmacy Services,...
Read moreHIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.
